Enhancing ADHD Medication Adherence: Challenges and Opportunities
Enhancing ADHD Medication Adherence: Challenges and Opportunities
复制标题
DOI：
10.1007/s11920-013-0371-6
复制
发表时间：
2013-07-01
影响因子：
6.7
通讯作者：
Fernandez, Rebeca
中科院分区：
文献类型：
--
作者：
Charach, Alice;Fernandez, Rebeca
治疗注意力缺陷多动障碍(ADHD)的药物是安全有效的，建议将其作为注意力不集中、过度活动和冲动等核心症状的一线治疗。尽管在青春期功能受损，许多人停止了药物治疗。对于儿童来说，医疗保健的决定通常是由父母做出的；年龄较大的年轻人自己做决定。信仰和态度可能大相径庭。一些家庭理解ADHD是一种神经生物学疾病，并接受药物治疗，对另一些家庭来说，这种治疗是不可接受的。越来越多的证据描述了对与药物使用相关的负担的负面看法，以及对潜在的短期和长期不良影响的担忧。事实上，不良影响的经历是年轻人停止戒烟的常见解释。改善从业者、家长和青年之间共同决策的方法，以及监测有效性、安全性和新出现的同时出现的困难，可能会优化结果。
Safe and effective medication for attention deficit hyperactivity disorder (ADHD) is available and recommended as first-line treatment for the core symptoms of inattention, overactivity and impulsiveness. Despite impaired functioning during adolescence, many discontinue medication treatment. For children, healthcare decisions are usually made by the parent; older youth make their own decisions. Beliefs and attitudes may differ widely. Some families understand that ADHD is a neurobiological condition and accept that medication is indicated, for others, such treatment is unacceptable. Converging evidence describes negative perceptions of the burden associated with medication use as well as concerns about potential short and long term adverse effects. Indeed experiences of adverse effects are a frequent explanation for discontinuation among youth. Ways to improve shared decision making among practitioners, parents and youth, and to monitor effectiveness, safety and new onset of concurrent difficulties are likely to optimize outcomes.